Danske Bank’s Lucid Diagnostics LUCD Stock Holding History
Bought
Maintained
Sold
Other funds holding LUCD
VCM
MCM
TSC
PCM
Danske Bank's LUCD Position: Q1 2026 in Review
Danske Bank held its Lucid Diagnostics (LUCD) position steady in Q1 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #1164.
Danske Bank first reported a position in LUCD in Q3 2024 and has held it in 7 quarters since. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.
- Danske Bank held 1 share of Lucid Diagnostics worth $1 as of Q1 2026.
- Danske Bank left its Lucid Diagnostics share count unchanged in Q1 2026.
- Lucid Diagnostics made up ﹤0.01% of Danske Bank's portfolio in Q1 2026, its #1164 holding.
- Danske Bank first reported a position in Lucid Diagnostics in Q3 2024 and has held it in 7 quarters since.
- 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.
Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.